To read this content please select one of the options below:

Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP

David Branford (STOMP, Learning Disability Programme, NHS England, Leicester, UK)
David Gerrard (STOMP, Learning Disability Programme, NHS England, Sunderland, UK)
Nigget Saleem (STOMP, Learning Disability Programme, NHS England, Bury, UK)
Carl Shaw (STOMP, NHS England, Sheffield, UK)
Anne Webster (Learning Disability Programme, NHS England, London, UK)

Advances in Mental Health and Intellectual Disabilities

ISSN: 2044-1282

Article publication date: 14 September 2018

Issue publication date: 8 February 2019

1976

Abstract

Purpose

The programme – Stopping the over-medication of people with an intellectual disability, Autism or Both (STOMP) is a three-year programme supported by NHS England. Concern about the overuse of antipsychotic drugs has been a constant theme since the 1970s. However, despite a multitude of guidelines the practice continues. The report into the events at Winterbourne View not only raised concerns about the overuse of antipsychotic drugs but of antidepressants and multiple psychotropic drug use. The purpose of this paper is twofold: Part 1 is to present the history and background to the use of psychotropic drugs in intellectual disabilities, autism or both; and Part 2 presents the progress with the STOMP programme.

Design/methodology/approach

The review tracks the various concerns, guidelines and attempts to tackle the issue of over medication of people with intellectual disability autism or both.

Findings

The review identifies that despite the many studies and guidelines associated with the prescribing of psychotropic drugs for people with an intellectual disability, autism or both the practice is common. Programmes that minimise the use of psychotropic drugs involve a full use of the multidisciplinary team and an availability of alternative methods of managing challenging behaviours.

Originality/value

STOMP is part of an English national agenda – Transforming care. The English Government and leading organisations across the health and care system are committed to transforming care for people with intellectual disabilities, autism or both who have a mental illness or whose behaviour challenges services. This review identifies many studies, programmes and guidelines associated with psychotropic drug use for people with an intellectual disability, autism or both.

Keywords

Citation

Branford, D., Gerrard, D., Saleem, N., Shaw, C. and Webster, A. (2019), "Stopping over-medication of people with intellectual disability, Autism or both (STOMP) in England part 1 – history and background of STOMP", Advances in Mental Health and Intellectual Disabilities, Vol. 13 No. 1, pp. 31-40. https://doi.org/10.1108/AMHID-02-2018-0004

Publisher

:

Emerald Publishing Limited

Copyright © 2018, Emerald Publishing Limited

Related articles